Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273

While mRNA vaccines are highly efficacious against short-term COVID-19, long-term immunogenicity is less clear. We compared humoral immunogenicity between BNT162b2 and mRNA-1273 vaccines 6 months after the first vaccine dose, examining the wild-type strain and multiple Delta-variant lineages. Using...

Descripción completa

Detalles Bibliográficos
Autores principales: Grunau, Brian, Golding, Liam, Prusinkiewicz, Martin A., Asamoah-Boaheng, Michael, Armour, Richard, Marquez, Ana Citlali, Jassem, Agatha N., Barakauskas, Vilte, O’Brien, Sheila F., Drews, Steven J., Haig, Scott, Lavoie, Pascal M., Goldfarb, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045183/
https://www.ncbi.nlm.nih.gov/pubmed/35254166
http://dx.doi.org/10.1128/spectrum.02702-21

Ejemplares similares

Ejemplares similares